|
2025
|
Invention
|
Microdystrophin gene therapy administration for treatment of dystrophinopathies.
Provided are me... |
|
|
Invention
|
Fully-human post-translationally modified antibody therapeutics.
Provided are methods and compos... |
|
|
G/S
|
Biological preparations for medical use in the treatment of genetic diseases and disorders, and m... |
|
|
Invention
|
Recombinant adeno-associated viruses and uses thereof. The present invention relates to recombina... |
|
|
Invention
|
Vectorized anti-complement antibodies and complement agents and administration thereof. Compositi... |
|
|
Invention
|
Treatment of ocular diseases with fully-human post-translationally modified anti-vegf fab.
Compo... |
|
2024
|
G/S
|
Biological preparations for medical use in the treatment of genetic diseases and disorders, and c... |
|
|
Invention
|
Compositions and methods for recombinant aav production. Provided herein are recombinant polynucl... |
|
|
Invention
|
Methods and formulations for treating mucopolysaccharidosis ii-associated hearing loss with recom... |
|
|
Invention
|
Anion exchange chromatography for recombinant aav production.
Provided herein are methods for th... |
|
|
Invention
|
Vectorized anti-complement antibodies and administration thereof. Compositions and methods are de... |
|
|
Invention
|
Adeno-associated viruses for ocular delivery of gene therapy. The present invention relates to re... |
|
|
Invention
|
Vectorized c5 inhibitor agents and administration thereof. Compositions and methods are described... |
|
|
Invention
|
Compositions and methods for recombinant aav production. Provided herein are host cells suitable ... |
|
|
Invention
|
Targeting aav capsids, methods of manufacturing and using same. The present invention relates to ... |
|
|
Invention
|
Exon skipping gene therapy constructs, vectors and uses thereof. Provided is an invention based, ... |
|
2023
|
G/S
|
Biological preparations for medical use; pharmaceutical
preparations, namely, recombinant adeno-... |
|
|
Invention
|
Engineered nucleic acid regulatory elements and methods and uses thereof. The present invention r... |
|
|
Invention
|
Treatment of ocular diseases with recombinant viral vectors encoding anti-vegf fab. Provided here... |
|
|
G/S
|
Biotechnological platform technology, namely, biological nanoparticles, recombinant viruses, and ... |
|
|
Invention
|
Auf1 gene therapy for limb girdle muscular dystrophy. Provided are methods of treating or amelior... |
|
|
Invention
|
Methods for recombinant aav production. Provided herein are improved methods for producing recomb... |
|
|
Invention
|
Vectorized anti-tnf-alpha inhibitors for ocular indications.
Compositions and methods are descri... |
|
|
Invention
|
Hybrid aav capsids.
Provided herein are hybrid adeno-associated viruses comprising VP1u and/or V... |
|
|
Invention
|
Gene therapy for treating an ocular disease.
Provided herein are gene therapy methods for the tr... |
|
|
Invention
|
Formulations for suprachoroidal administration such as formulations with aggregate formation.
Pr... |
|
|
Invention
|
Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapy.
The present d... |
|
|
Invention
|
Modified muscle-specific promoters.
Disclosed are nucleic acids comprising or consisting of the ... |
|
2022
|
G/S
|
Providing medical and scientific research information in the field of clinical trials; Medical an... |
|
|
Invention
|
Engineered nucleic acid regulatory elements and methods and uses thereof.
The present invention ... |
|
|
Invention
|
Antibodies and methods of using thereof.
Provided herein are antibodies that specifically bind t... |
|
|
Invention
|
Recombinant adeno-associated viruses for cns tropic delivery.
The present invention relates to r... |
|
|
Invention
|
Compositions and methods for recombinant aav production.
Provided herein are recombinant polynuc... |
|
|
G/S
|
Providing medical and scientific research information in the
field of clinical trials; medical a... |
|
|
G/S
|
Providing medical and scientific research information in the field of clinical trials; medical an... |
|
|
G/S
|
Custom manufacture of reagents for scientific and medical research and development; Custom manufa... |
|
|
G/S
|
Biotechnological platform technology, namely, cell lines for preparation of biological vectors, a... |
|
|
Invention
|
Methods and compositions for treating epilepsy.
Disclosed are methods and compositions relating ... |
|
|
Invention
|
Treatment of duchenne muscular dystrophy and combinations thereof.
Provided are methods of treat... |
|
|
Invention
|
Novel aav vectors and methods and uses thereof.
The present invention relates to nucleic acid ex... |
|
|
Invention
|
Improved production of recombinant polypeptides and viruses.
Provided herein are improved method... |
|
2021
|
Invention
|
Tau-specific antibody gene therapy compositions, methods and uses thereof.
The present invention... |
|
|
Invention
|
Method of producing a recombinant virus particle.
Provided herein are improved methods for produ... |
|
|
Invention
|
Vectorized tnf-alpha antagonists for ocular indications.
Provided are methods and compositions f... |
|
|
Invention
|
Vectorized factor xii antibodies and administration thereof.
Compositions and methods are descri... |
|
|
Invention
|
Vectorized anti-cgrp and anti-cgrpr antibodies and administration thereof.
Compositions and meth... |
|
|
Invention
|
Vectorized anti-tnf-alpha antibodies for ocular indications.
Compositions and methods are descri... |
|
|
Invention
|
Adeno-associated viruses for ocular delivery of gene therapy.
The present invention relates to r... |
|
|
Invention
|
Formulations for suprachoroidal administration such as high viscosity formulations.
Provided her... |
|
|
Invention
|
Formulations for suprachoroidal administration such as gel formulations.
Provided herein are pha... |
|
|
Invention
|
Vectorized lanadelumab and administration thereof.
Compositions and methods are described for th... |
|
|
Invention
|
Methods and compositions for treating epilepsy.
The present disclosure provides methods and comp... |
|
2020
|
Invention
|
Adeno-associated virus vector pharmaceutical composition and methods.
Provided herein are pharma... |
|
|
G/S
|
Medical and scientific research, namely, conducting clinical trials for others, all the above for... |
|
2019
|
G/S
|
Medical services in the field of biotechnology, namely, biological nanoparticles, recombinant vir... |
|
|
G/S
|
Medical services in the field of biotechnology, namely, providing medical treatment services focu... |
|
|
G/S
|
Scientific research and development in the field of
biotechnology, namely, biological nanopartic... |
|
|
G/S
|
Scientific research and development in the field of biotechnology, namely, biological nanoparticl... |
|
|
G/S
|
Providing medical and scientific research information in the field of clinical trials in the fiel... |
|
|
G/S
|
Providing medical and scientific research information in the
field of clinical trials; Medical a... |
|
|
Invention
|
Scalable clarification process for recombinant aav production. Provided herein are scalable metho... |
|
2018
|
G/S
|
Providing medical and scientific research information in the field of clinical trials |
|
|
G/S
|
Custom development of biochemical reagents, namely,
synthesis for others of clinical medical rea... |
|
2015
|
G/S
|
Custom development of biochemical reagents, namely, synthesis for others of clinical medical reag... |
